Skip to main content
SpringerLink
Log in

The effects of liposome-encapsulated and free clodronate on the growth of macrophage-like cellsin vitro: The role of calcium and iron

  • Laboratory Investigations
  • Published:
Calcified Tissue International Aims and scope Submit manuscript

Summary

Clodronate (dichloromethylene bisphosphonate) inhibits the activity of osteoclasts, thereby preventing bone resorption in disorders characterized by excessive bone loss. Intravenously injected clodronate encapsulated in liposomes is also known to inactivate phagocytic cells in spleen and liverin vivo. The macrophage suppressive effect of clodronate is of interest in autoimmune diseases, like rheumatoid arthritis, in which phagocytic cells are involved in inflammatory processes, but knowledge of the interaction of clodronate with phagocytic cells is scarce. We have studied the uptake of clodronate, both free and encapsulated in negatively charged liposomes, by the macrophage-like cell line RAW 264 and by other types of cell lines. The uptake was assessed by a growth inhibition assay. The liposome-encapsulated lodronate was 50 and 350 times more potent than free drug for RAW 264 and CVI-P, respectively. Cell lines with a lower endocytotic capacity were insensitive to liposome-mediated delivery of the drug. The action of free clodronate seemed to be extracellular in all cell lines studied. Calcium and/or iron have been suggested to be involved in the intracellular uptake and action of clodronate in phagocytic cells. We found that the uptake of free clodronate by RAW 264 cells was indeed mediated by calcium and iron, while the uptake of liposomal drugs was only slightly affected by calcium. The increased intracellular calcium concentration in macrophages did not significantly affect the growth-inhibitory properties of clodronate, whereas iron loading of the cells partially restored the cell growth. The data do not support the role of calcium chelation as a mechanism of action of clodronate, but suggest that intracellular iron is, at least partially involved.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Fleisch H (1991) Bisphosphonates. Pharmacology and use in the treatment of tumor-induced hypercalcaemia and metastatic bone disease. Drugs 42:919–942

    Google Scholar 

  2. Mönkkönen J, Koponen H-M, Ylitalo P (1990) Comparison of distribution of three bisphosphonates in mice. Pharmacol Toxicol 66:294–298

    Google Scholar 

  3. Mönkkönen J, Urtti A, Paronen P, Elo HA, Ylitalo P (1989) The uptake of clodronate (dichloromethylene bisphosphonate) by macrophages in vivo and in vitro. Drug Metab Dispos 17:690–693

    Google Scholar 

  4. Mönkkönen J, Ylitalo P (1990) The tissue distribution of clodronate (dichloromethylene bisphosphonate) in mice. The effects of vehicle and the route of administration. Eur J Drug Metab Pharmacokin 15:239–243

    Google Scholar 

  5. Van Rooijen N (1992) Liposome-mediated elimination of macrophages. Res Immunol 143:215–219

    Google Scholar 

  6. Flanagan AM, Chambers TJ (1989) Dichloromethylene bisphosphonate (Cl2MBP) inhibits bone resorption through injury to osteoclasts that resorb Cl2-MBP-coated bone. Bone Miner 6:33–43

    Google Scholar 

  7. Carano A, Teitelbaum SLO, Konsek JD, Schlesinger PH, Blair HC (1990) Bisphosphonates directly inhibit the bone resorption activity of isolated avian osteoclasts in vitro. JClin Invest 85:456–461

    Google Scholar 

  8. Chambers TJ (1980) Diphosphonates inhibit bone resorption by macrophages in vitro. J Pathol 132:255–262

    Google Scholar 

  9. Van Rooijen N (1989) The liposome-mediated macrophage “suicide” technique. J Immunol Methods 124:1–6

    Google Scholar 

  10. Van Rooijen N, Van Nieuwmegen R (1984) Elimination of phagocytic cells in the spleen after intravenous injection of liposome-encapsulated dichloromethylene disphosphonate. An enzyme-histochemical study. Cell Tissue Res 238:355–358

    Google Scholar 

  11. Mönkkönen J, Van Rooijen N, Ylitalo P (1991) Effects of clodronate and pamidronate on splenic and hepatic phagocytic cells of mice. Pharmacol Toxicol 68:284–286

    Google Scholar 

  12. Van Rooijen N (1991) High and low cytosolic Ca2+ induced macrophage death? Hypothesis. Cell Calcium 12:381–384

    Google Scholar 

  13. Van Lent PLEM, Van den Hoek A, Van den Bersselaar, Dijkstra CD, Van Rooijen N, Van den Berg WB (1992) Role of synovial macrophages in experimental arthritis. Res Immunol 143:229–234

    Google Scholar 

  14. Bresnihan B (1992) The synovial lining cells in chronic arthritis. Br J Rheumatol 31:433–436

    Google Scholar 

  15. Szoka FC, Papahadjopoulos D (1978) Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation. Proc Natl Acad Sci USA 75:4194–4198

    Google Scholar 

  16. Heath TD, Brown CS (1990) Liposome dependent delivery of N-(phosphonacetyl)-L-aspartic acid to cells in vitro. J Lipos Res 1:315–329

    Google Scholar 

  17. Claassen E, Van Rooijen N (1986) Preparation and characteristics of dichloromethylene diphosphonate-containing liposomes. J Microencapsul 3:109–114

    Google Scholar 

  18. Bartlett GR (1959) Phosphorus assay in column chromatography. J Biol Chem 234:466–468

    Google Scholar 

  19. Ponka P, Borova J, Neuwirt J, Fuchs O (1979) Mobilization of iron from reticulocytes. FEBS Lett 97:317–321

    Google Scholar 

  20. Heath TD, Lopez NG, Papahadjopoulos D (1985) The effects of liposome size and surface charge on liposome-mediated delivery of methotrexate-γ-aspartate to cells in vitro. Biochim Biophys Acta 820:74–84

    Google Scholar 

  21. Ng K, Heath TD (1989) Liposome-dependent delivery of pteridine antifolates: A two compartment growth inhibition assay for the evaluating drug leakage and metabolism. Biochim Biophys Acta 981:261–268

    Google Scholar 

  22. Heath TD, Lopez NG, Piper JR, Montgomery JA, Stern WH, Papahadjopoulos D (1986) Liposome-mediated delivery of pteridine antifolates to cells in vitro: Potency of methotrexate, and its α and γ substituents. Biochim Biophys Acta 862:72–80

    Google Scholar 

  23. Van Rooijen N, Claassen E (1988) In vivo elimination of macrophages in spleen and liver, using liposome-encapsulated drugs: Methods and applications. In: Gregoriadis G (ed) Lipo somes as drug carriers. John Wiley & Sons, Chichester, pp 131–143

    Google Scholar 

  24. Van Rooijen N, Kors N, ter Hart H, Claassen E (1988) In vitro and in vivo elimination of macrophage tumor cells using liposome-encapsulated dichloromethylene diphosphonate. Virchows Archiv B Cell Pathol 54:251–245

    Google Scholar 

  25. Claassen I, Van Rooijen N, Claassen E (1990) A new method for removal of mononuclear phagocytes from heterogeneous cell populations in vitro, using the liposome-mediated macrophage ‘suicide’ technique. J Immunol Methods 134:153–161

    Google Scholar 

  26. Van Rooijen N, Van Nieuwmegen N, Kamperdijk EWA (1985) Elimination of phagocytic cells in the spleen after intravenous injection of liposome-encapsulated dichloromethylene disphosphonate. Ultrastructural aspects of elimination of marginal zone macrophages. Virchows Arch B Cell Pathol 49:375–383

    Google Scholar 

  27. Van Rooijen N, Kors N, Kraal G (1989) Macrophage subset repopulation in the spleen: differential kinetics after liposome mediated elimination. J Leukoc Biol 45:97–104

    Google Scholar 

  28. Cecchini MG, Felix R, Fleisch H, Cooper PH (1987) Effect of bisphosphonates on proliferation and viability of mouse bone marrow derived macrophages. J Bone Miner Res 2:135–142

    Google Scholar 

  29. Cecchini MG, Fleisch H (1990) Bisphosphonates in vitro specifically inhibit, among the hematopoietic series, the development of the mouse mononuclear phagocyte lineage. J Bone Miner Res 5:1019–1027

    Google Scholar 

  30. Zimolo Z, Tanaka H, Rodan GA (1992) Alendronate (ALN) increases the membrane permeability of multinucleated osteoclast-like cells to NH4 +, H+ and Ca.2+. Bone Miner 17(Suppl 1):S17

    Google Scholar 

  31. Rao K, van Renswoude J, Kempf C, Klausner RD (1983) Separation of Fe3+ from transferrin in endocytosis. Role of the acidic endosomes. FEBS Lett 160:213–216

    Google Scholar 

  32. Hagenlocker BE, Walker BAM, Ward PA (1990) Superoxide responses of immune complex-stimulated rat alveolar macrophages. J Immunol 144:3898–3906

    Google Scholar 

  33. Landschulz W, Thesleff I, Ekblom P (1984) A lipophilic iron chelator can replace transferrin as a stimulator of cell proliferation and differentiation. J Cell Biol 98:596–601

    Google Scholar 

  34. Chitambar CR, Matthaeus WG, Antholine WE, Graff K, O'Brien JO (1988) Inhibition of leukemic HL60 cell growth by transferrin-gallium: effects on ribonucleotide reductase and demonstration of drug synergy with hydroxyurea. Blood 72:1930–1936

    Google Scholar 

  35. Lundberg JH, Chitambar CR (1990) Interaction of gallium nitrate with fludarabine and iron chelators: Effects on the proliferation of human leukemic HL60 cells. Cancer Res 50:6466–6470

    Google Scholar 

  36. Chitambar CR, Zivkovic Z (1987) Inhibition of hemoglobin production by transferrin-gallium. Blood 69:144–149

    Google Scholar 

  37. Ponka P, Schulman HM, Wilczynska A (1982) Ferric pyridoxal isonicotinoyl hydrazone can provide iron for heme synthesis in reticulocytes. Biochim Biophys Acta 718:151–156

    Google Scholar 

  38. Mönkkönen J, Brown CS, Thompson TT, Heath TD (1993) Liposome mediated delivery of gallium to macrophage-like cells in vitro: demonstration of transferrin independent route for intracellular delivery of metal ions. Pharm Res (in press)

  39. D'Arcy Hart P, Young MR (1991) Ammonium chloride, an inhibitor of phagosome-lysosome fusion in macrophages, concurrently induces phagosome-endosome fusion, and opens a novel pathway: Studies of a pathogenic mycobacterium and nonpathogenic yeast. J Exp Med 174:881–889

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. School of Pharmacy, University of Wisconsin, 53706, Madison, WI, USA

    Jukka Mönkkö & Timothy D. Heath

  2. Department of Pharmaceutical Technology and A. I. Virtanen Institute, University of Kuopio, P.O. Box 1627, 70211, Kuopio, Finland

    Jukka Mönkkö

Authors
  1. Jukka Mönkkö
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Timothy D. Heath
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mönkkö, J., Heath, T.D. The effects of liposome-encapsulated and free clodronate on the growth of macrophage-like cellsin vitro: The role of calcium and iron. Calcif Tissue Int 53, 139–146 (1993). https://doi.org/10.1007/BF01321893

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01321893

Key words

Search

Navigation